Nabota® is an FDA-approved botulinum toxin type A manufactured by Daewoong Pharmaceutical in South Korea. It is recognized for its high purity and advanced manufacturing process, delivering consistent and reliable aesthetic results.
Nabota is an excellent option for patients who have experienced reduced responsiveness to other botulinum toxin brands. Its highly purified formulation is designed to minimize the risk of neutralizing antibody formation, making it a preferred choice for individuals seeking long-term treatment effectiveness.
With an exceptionally low reported antibody-related resistance rate of less than 0.00001%, Nabota may help maintain treatment efficacy even in patients who have developed resistance to other botulinum toxin products.
Key Benefits
- FDA-approved botulinum toxin type A
- Manufactured by Daewoong Pharmaceutical, South Korea
- High-purity formulation for consistent performance
- May be suitable for patients with reduced response to other botulinum toxin brands
- Exceptionally low reported antibody-related resistance rate (<0.00001%)


Reviews
There are no reviews yet.